Hinge Health, Inc. (HNGE) stock: key figures, P/E, revenue and dividend

Information Technology · United States · ISIN US4333131039

Price
107.51 USD
Market cap
5.87 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Hinge Health, Inc. financials

Fiscal year2025
Revenue587.86 m USD
Gross profit468.22 m USD
Operating income-546.37 m USD
EBIT-527.26 m USD
Net income-528.26 m USD
Diluted EPS – continuing operations-7.77 USD

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.

Hinge Health, Inc. stock (HNGE): P/E, revenue, dividend | finmetric